TPHA

Infectious Disease Core Test Offerings

TURN AROUND TIME

8-12 Hours

TEST INFO

SAMPLE INFO

Test Name
TPHA
Test Site
  • Colorado
Test Description
TPHA is a treponemal-based Syphilis screening assay. TPHA Screen (Immucor) is intended for use in the qualitative screening of blood donors for the detection of IgG and IgM antibodies to Treponema pallidum in human serum and EDTA plasma by passive hemagglutination.
CyberLAB Test Info

Test Name

Test #

TPHA

3549

Method Description
  • Hemagglutination
FDA Cleared / Approved
No
CPT Code(s)
  • 86592
STAT Allowed
Yes
Notes
Currently, there is no treponemal donor screening test for Syphilis specifically licensed for use in testing cadaveric specimens. LABS, Inc. has validated this test kit for use with cadaveric specimens.
Download(s)
Draw Status

Cadaveric

Sample Volume
Minimum Sample Volume
  • Serum/Plasma: 250 uL
Preferred Sample Volume
  • Serum/Plasma: 500 uL
Sample Type
Acceptable
  • Plasma, EDTA - Lavender Top Tube
  • Serum - Red Top Tube
Sample Stability
  • Frozen at -20°C - Indefinite
  • Refrigerated 1-10°C - 7 days
Transport
  • Frozen at -20°C – Greater than 7 Days
  • Refrigerated 1-10°C - Up to 7 Days
Notes
No neutral gel separator tubes